在患有侵袭性差差分化的甲状腺癌的患者中使用新辅助剂列巴替尼布
Santiago Zund1,2, Inés Califano3, Fernando Carrizo4
1Department of Head and Neck Surgery, Instituto de Oncología Ángel H. Roffo (IOAHR), University of Buenos Aires, Buenos Aires C1417DTB, CABA, Argentina.
Ecancermedicalscience
|June 11, 2025
概括
新辅助剂伦瓦提尼布可以缩小局部侵袭性差差分化甲状腺癌 (PDTC),使手术成为可能. 这种向疗法对精选患者有前途,可能改善结果.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
背景情况:
- 在局部侵袭性差差差分化的甲状腺癌 (PDTC) 中,用于新辅助治疗的铁氨酸激酶抑制剂的研究有限.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K